← All stocks

NEPHROS INC

NEPH Net buying

CIK 0001196298 #4710 in the set updated 22 Sep 2026

Bought (120 mo)

$592.74K

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

+$592.74K

+$592.74K against sales at will

By person

15 insiders · 73 transactions

1.2×

Robert Banks holds only 1.2 times base salary in stock. $426.53K of shares against $350.00K in salary for 2024.

Salary from the company's own proxy. The shares are what Robert Banks last reported holding, valued at $2.24, the price Common Stock was last bought or sold at on the open market here, on 30 May 2024.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Evans Daron

CEO of Specialty Renal Product

$179.06K (29)

—

+$179.06K

160,416

1.48%

$360.12K

—

Astor Andrew

President, CEO & CFO

$165.67K (18)

—

+$165.67K

92,773

0.8543%

$208.27K

—

Banks Robert R. Jr.

President and CEO

$155.05K (4)

—

+$155.05K

190,000

1.75%

$426.53K

—

Gwydir Tom

Director

$38.20K (1)

—

+$38.20K

43,226

0.3980%

$97.04K

—

Amron Arthur H

Director

$28.31K (3)

—

+$28.31K

184,169

1.70%

$413.44K

—

Spandow Oliver J.

Director

$16.92K (2)

—

+$16.92K

122,881

1.13%

$275.86K

—

Lobo Wesley S.

Chief Marketing Officer

$7.92K (1)

—

+$7.92K

35,168

0.3238%

$78.95K

—

Lask Alisa

Director

$1.61K (1)

—

+$1.61K

48,629

0.4478%

$109.17K

—

WEXFORD CAPITAL LP entity

10% owner

—

223,539

2.06%

$501.82K

−93.5%

Pinto Moshe

Director

—

204,118

1.88%

$458.22K

+258.7%

Krandel Judy

Chief Financial Officer

—

68,861

0.6341%

$154.59K

—

PERSEN MALCOLM C

Director

—

53,968

0.4969%

$121.15K

—

Harris Joseph Michael

Director

—

17,693

0.1629%

$39.72K

—

Mieyal Paul A

Director

—

3,448

0.0317%

$7.74K

—

Nettis Lisa Marie

Director

—

1,622

0.0149%

$3.64K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

WEXFORD CAPITAL LP

18 Aug 2026

10% owner

Exercised, kept

812

$3.60

$2.92K

Krandel Judy

23 Mar 2026

Chief Financial Officer

Exercised, kept

68,861

$1.71

$117.75K

Banks Robert R. Jr.

23 Mar 2026

President and CEO

Exercised, kept

120,000

$1.44

$172.80K

Astor Andrew

5 Mar 2022

President, CEO & CFO

Exercised, kept

14,815

$2.70

$40.00K

WEXFORD CAPITAL LP

1 Jun 2021

Director

Exercised, kept indirect

66,667

$2.70

$180.00K

Evans Daron

24 May 2021

CEO of Specialty Renal Product

Exercised, kept indirect

1,111

$2.70

$3.00K

Evans Daron

24 May 2021

CEO of Specialty Renal Product

Exercised, kept indirect

1,111

$2.70

$3.00K

WEXFORD CAPITAL LP

27 Jan 2021

Director

Exercised, kept

4,477

$4.50

$20.15K

WEXFORD CAPITAL LP

27 Jan 2021

Director

Exercised, kept

3,765

$3.60

$13.55K

WEXFORD CAPITAL LP

27 Jan 2021

Director

Exercised, kept

2,956

$4.14

$12.24K

WEXFORD CAPITAL LP

27 Jan 2021

Director

Exercised, kept

3,556

$4.59

$16.32K

PERSEN MALCOLM C

11 May 2020

Director

Exercised, kept indirect

1,732

$7.65

$13.25K

Evans Daron

14 May 2018

President and CEO

Exercised, kept indirect

40,000

$0.30

$12.00K

Astor Andrew

14 May 2018

Chief Financial Officer

Exercised, kept

33,333

$0.30

$10.00K

Show all 73 transactions →

NEPHROS INC

By person

Individual transactions

What was left out